As Chief Manufacturing Officer at Revival, Dylan brings a science-driven approach to manufacturing excellence in the cannabis industry. He oversees end-to-end production processes, ensuring operational efficiency, rigorous quality control, and strict regulatory compliance from post-harvest stages to the final product. Dylan's expertise spans protein chemistry, crystallography, laboratory automation, and cGMP drug production. He is highly skilled in data analysis, process optimization, and strategic planning, which have been integral to his success in advancing drug manufacturing and research. His previous scientific roles at Curia and ONY Biotech allowed him to contribute to significant advancements in drug research and development, emphasizing process validation and the refinement of production workflows. Dylan Clapp holds both a Bachelor of Science and a Master of Science in Pharmacology and Toxicology from the University at Buffalo, graduating in 2020.